NRx Pharmaceuticals Debt/Equity Ratio 2018-2024 | NRXP
NRx Pharmaceuticals debt/equity ratio from 2018 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.